Trial
NCT00702962
Carboplatin and Etoposide in Combination With Vorinostat for Patients With Extensive Stage Small Cell Lung Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Milton S. Hershey Medical Center
Collaborators
Merck Sharp & Dohme LLC; University of Pennsylvania
Condition
Small Cell Lung Cancer
Intervention
Vorinostat, Carboplatin, Etoposide
Why stopped
Poor accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-10-22